a nonsignificant trendP = 0.102
Although the trial was not powered to detect a mortality difference, there was a nonsignificant trend towards reduced 30-day mortality (37% versus 52%, P = 0.102) in the HFOV group, which persisted at 90 days.
Although the trial was not powered to detect a mortality difference, there was a nonsignificant trend towards reduced 30-day mortality (37% versus 52%, P = 0.102) in the HFOV group, which persisted at 90 days.